These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20545111)

  • 1. [Expression of MMP-9 and TIMP-1 in nasopharyngeal carcinoma and its signification at Xi'an and Shenzhen].
    Wang H; Jing Y; Zheng J; Wang M
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Apr; 24(7):296-8. PubMed ID: 20545111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and significance of matrix metalloproteinase and tissue inhibitor of metalloproteinase in nasal cavity squamous cell carcinoma].
    Zheng Y; Ding J; Wang CL; Jiao SS; Qu LM; Bahargul ; Bao H; Chen X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Apr; 46(4):299-302. PubMed ID: 21624249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
    Zhang S; Li L; Lin JY; Lin H
    World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
    Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expressions of COX-2 and MMP-2 in nasopharyngeal carcinoma and the their relationship with lymph node metastasis].
    Cui D; Zhang X; Fu Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Aug; 22(15):692-4. PubMed ID: 18950008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
    Zhou CY; Yao JF; Chen XD
    Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma.
    Matulka M; Konopka A; Mroczko B; Pryczynicz A; Kemona A; Groblewska M; Sieskiewicz A; Olszewska E
    Dis Markers; 2019; 2019():3136792. PubMed ID: 31143300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors.
    Bodnar M; Szylberg Ł; Kazmierczak W; Marszalek A
    J Oral Pathol Med; 2015 Jul; 44(6):437-43. PubMed ID: 25244188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas.
    Ondruschka C; Buhtz P; Motsch C; Freigang B; Schneider-Stock R; Roessner A; Boltze C
    Pathol Res Pract; 2002; 198(8):509-15. PubMed ID: 12389993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunohistochemical characterization of MMP-2, MMP-10, TIMP-1, TIMP-2, and podoplanin in oral squamous cell carcinoma.
    Mashhadiabbas F; Mahjour F; Mahjour SB; Fereidooni F; Hosseini FS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Aug; 114(2):240-50. PubMed ID: 22769410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 and cervical lymph node metastasis of nasopharyngeal carcinoma.
    Huang T; Chen MH; Wu MY; Wu XY
    Ann Otol Rhinol Laryngol; 2013 Mar; 122(3):210-5. PubMed ID: 23577575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY; Wu YQ; Fan SQ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease].
    Kong YJ; Sun WX; Zhang YM; Shi YZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Feb; 31(2):129-33. PubMed ID: 18683786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of MMP-13 and TIMP-1 in head and neck squamous cell carcinomas may reflect increased tumor invasiveness.
    Culhaci N; Metin K; Copcu E; Dikicioglu E
    BMC Cancer; 2004 Aug; 4():42. PubMed ID: 15291964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of cisplatin on expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and their correlations in Lewis lung cancer in mice].
    Li CJ; Sun JL; Jiang WJ; Liu LS; Sun XY; Fan GZ
    Ai Zheng; 2009 Jul; 28(7):685-90. PubMed ID: 19624892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2--complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma.
    Hoikkala S; Pääkkö P; Soini Y; Mäkitaro R; Kinnula V; Turpeenniemi-Hujanen T
    Cancer Lett; 2006 May; 236(1):125-32. PubMed ID: 15982804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma.
    Gao ZB; Duan YQ; Zhang L; Chen DW; Ding PT
    Int J Mol Med; 2005 Oct; 16(4):599-603. PubMed ID: 16142392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Matrix metalloproteinase 2 and 9 as the factor of head and neck tumor metastasis].
    Kondakova IV; Klisho EV; savenkova OV; Kakurina GV; Choĭnzonov EL; Shishkin DA; Mukhamedov MP
    Biomed Khim; 2008; 54(5):555-60. PubMed ID: 19105397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.